Go Pro

Cardinal Health (CAH) Competitors

Cardinal Health logo
$236.06 -0.34 (-0.14%)
As of 12:05 PM Eastern
This is a fair market value price provided by Massive. Learn more.

CAH vs. DXCM, MMSI, AMN, COR, and ELV

Should you buy Cardinal Health stock or one of its competitors? MarketBeat compares Cardinal Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Cardinal Health include DexCom (DXCM), Merit Medical Systems (MMSI), AMN Healthcare Services (AMN), Cencora (COR), and Elevance Health (ELV). These companies are all part of the "healthcare" sector.

How does Cardinal Health compare to DexCom?

DexCom (NASDAQ:DXCM) and Cardinal Health (NYSE:CAH) are both large-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, dividends, profitability, institutional ownership, risk, analyst recommendations and media sentiment.

DexCom has a beta of 1.41, indicating that its stock price is 41% more volatile than the broader market. Comparatively, Cardinal Health has a beta of 0.49, indicating that its stock price is 51% less volatile than the broader market.

DexCom currently has a consensus price target of $88.71, suggesting a potential upside of 1.47%. Cardinal Health has a consensus price target of $251.73, suggesting a potential upside of 6.23%. Given Cardinal Health's higher possible upside, analysts plainly believe Cardinal Health is more favorable than DexCom.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DexCom
1 Sell rating(s)
3 Hold rating(s)
21 Buy rating(s)
2 Strong Buy rating(s)
2.89
Cardinal Health
0 Sell rating(s)
3 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.83

In the previous week, DexCom had 13 more articles in the media than Cardinal Health. MarketBeat recorded 21 mentions for DexCom and 8 mentions for Cardinal Health. DexCom's average media sentiment score of 0.85 beat Cardinal Health's score of 0.61 indicating that DexCom is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DexCom
12 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Cardinal Health
1 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Cardinal Health has higher revenue and earnings than DexCom. DexCom is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DexCom$4.66B7.08$836.30M$2.5334.55
Cardinal Health$250.74B0.22$1.56B$6.5436.23

97.8% of DexCom shares are held by institutional investors. Comparatively, 87.2% of Cardinal Health shares are held by institutional investors. 0.3% of DexCom shares are held by insiders. Comparatively, 0.1% of Cardinal Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

DexCom has a net margin of 20.12% compared to Cardinal Health's net margin of 0.62%. DexCom's return on equity of 35.94% beat Cardinal Health's return on equity.

Company Net Margins Return on Equity Return on Assets
DexCom20.12% 35.94% 14.75%
Cardinal Health 0.62%-92.61%4.46%

Summary

DexCom beats Cardinal Health on 12 of the 17 factors compared between the two stocks.

How does Cardinal Health compare to Merit Medical Systems?

Merit Medical Systems (NASDAQ:MMSI) and Cardinal Health (NYSE:CAH) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, institutional ownership, media sentiment, valuation, earnings, dividends, analyst recommendations and risk.

In the previous week, Merit Medical Systems had 1 more articles in the media than Cardinal Health. MarketBeat recorded 9 mentions for Merit Medical Systems and 8 mentions for Cardinal Health. Merit Medical Systems' average media sentiment score of 0.76 beat Cardinal Health's score of 0.61 indicating that Merit Medical Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Merit Medical Systems
5 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cardinal Health
1 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Merit Medical Systems has a beta of 0.48, indicating that its stock price is 52% less volatile than the broader market. Comparatively, Cardinal Health has a beta of 0.49, indicating that its stock price is 51% less volatile than the broader market.

Merit Medical Systems has a net margin of 9.22% compared to Cardinal Health's net margin of 0.62%. Merit Medical Systems' return on equity of 13.75% beat Cardinal Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Merit Medical Systems9.22% 13.75% 8.10%
Cardinal Health 0.62%-92.61%4.46%

Cardinal Health has higher revenue and earnings than Merit Medical Systems. Cardinal Health is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Merit Medical Systems$1.52B3.56$128.49M$2.4237.38
Cardinal Health$250.74B0.22$1.56B$6.5436.23

99.7% of Merit Medical Systems shares are owned by institutional investors. Comparatively, 87.2% of Cardinal Health shares are owned by institutional investors. 0.7% of Merit Medical Systems shares are owned by insiders. Comparatively, 0.1% of Cardinal Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Merit Medical Systems currently has a consensus target price of $100.30, suggesting a potential upside of 10.87%. Cardinal Health has a consensus target price of $251.73, suggesting a potential upside of 6.23%. Given Merit Medical Systems' higher possible upside, research analysts clearly believe Merit Medical Systems is more favorable than Cardinal Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Merit Medical Systems
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73
Cardinal Health
0 Sell rating(s)
3 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.83

Summary

Merit Medical Systems beats Cardinal Health on 10 of the 16 factors compared between the two stocks.

How does Cardinal Health compare to AMN Healthcare Services?

Cardinal Health (NYSE:CAH) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings, media sentiment and analyst recommendations.

Cardinal Health has a beta of 0.49, indicating that its stock price is 51% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.4, indicating that its stock price is 60% less volatile than the broader market.

Cardinal Health pays an annual dividend of $2.06 per share and has a dividend yield of 0.9%. AMN Healthcare Services pays an annual dividend of $1.20 per share and has a dividend yield of 3.3%. Cardinal Health pays out 31.5% of its earnings in the form of a dividend. AMN Healthcare Services pays out 44.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cardinal Health has raised its dividend for 29 consecutive years.

Cardinal Health has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardinal Health$250.74B0.22$1.56B$6.5436.23
AMN Healthcare Services$3.43B0.40-$95.70M$2.6813.37

87.2% of Cardinal Health shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 0.1% of Cardinal Health shares are held by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

AMN Healthcare Services has a net margin of 3.06% compared to Cardinal Health's net margin of 0.62%. AMN Healthcare Services' return on equity of 19.92% beat Cardinal Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Cardinal Health0.62% -92.61% 4.46%
AMN Healthcare Services 3.06%19.92%5.93%

Cardinal Health presently has a consensus target price of $251.73, suggesting a potential upside of 6.23%. AMN Healthcare Services has a consensus target price of $30.86, suggesting a potential downside of 13.88%. Given Cardinal Health's stronger consensus rating and higher probable upside, research analysts clearly believe Cardinal Health is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cardinal Health
0 Sell rating(s)
3 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.83
AMN Healthcare Services
2 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.22

In the previous week, AMN Healthcare Services had 15 more articles in the media than Cardinal Health. MarketBeat recorded 23 mentions for AMN Healthcare Services and 8 mentions for Cardinal Health. AMN Healthcare Services' average media sentiment score of 0.71 beat Cardinal Health's score of 0.61 indicating that AMN Healthcare Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cardinal Health
1 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
AMN Healthcare Services
8 Very Positive mention(s)
4 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Cardinal Health beats AMN Healthcare Services on 10 of the 19 factors compared between the two stocks.

How does Cardinal Health compare to Cencora?

Cardinal Health (NYSE:CAH) and Cencora (NYSE:COR) are both large-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, earnings, profitability, media sentiment, institutional ownership, risk and dividends.

Cardinal Health pays an annual dividend of $2.06 per share and has a dividend yield of 0.9%. Cencora pays an annual dividend of $2.40 per share and has a dividend yield of 0.7%. Cardinal Health pays out 31.5% of its earnings in the form of a dividend. Cencora pays out 17.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cardinal Health has increased its dividend for 29 consecutive years and Cencora has increased its dividend for 15 consecutive years. Cardinal Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Cardinal Health has higher earnings, but lower revenue than Cencora. Cencora is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardinal Health$250.74B0.22$1.56B$6.5436.23
Cencora$321.33B0.20$1.55B$13.4624.09

Cardinal Health has a beta of 0.49, meaning that its share price is 51% less volatile than the broader market. Comparatively, Cencora has a beta of 0.57, meaning that its share price is 43% less volatile than the broader market.

Cardinal Health currently has a consensus target price of $251.73, indicating a potential upside of 6.23%. Cencora has a consensus target price of $368.92, indicating a potential upside of 13.79%. Given Cencora's stronger consensus rating and higher probable upside, analysts plainly believe Cencora is more favorable than Cardinal Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cardinal Health
0 Sell rating(s)
3 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.83
Cencora
0 Sell rating(s)
2 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.87

In the previous week, Cencora had 20 more articles in the media than Cardinal Health. MarketBeat recorded 28 mentions for Cencora and 8 mentions for Cardinal Health. Cencora's average media sentiment score of 0.76 beat Cardinal Health's score of 0.61 indicating that Cencora is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cardinal Health
1 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive
Cencora
8 Very Positive mention(s)
6 Positive mention(s)
10 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Cencora has a net margin of 0.79% compared to Cardinal Health's net margin of 0.62%. Cencora's return on equity of 125.45% beat Cardinal Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Cardinal Health0.62% -92.61% 4.46%
Cencora 0.79%125.45%4.18%

87.2% of Cardinal Health shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 0.1% of Cardinal Health shares are held by company insiders. Comparatively, 0.4% of Cencora shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Cencora beats Cardinal Health on 12 of the 19 factors compared between the two stocks.

How does Cardinal Health compare to Elevance Health?

Elevance Health (NYSE:ELV) and Cardinal Health (NYSE:CAH) are both large-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations, valuation and media sentiment.

Elevance Health has a beta of 0.68, meaning that its share price is 32% less volatile than the broader market. Comparatively, Cardinal Health has a beta of 0.49, meaning that its share price is 51% less volatile than the broader market.

Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.7%. Cardinal Health pays an annual dividend of $2.06 per share and has a dividend yield of 0.9%. Elevance Health pays out 30.6% of its earnings in the form of a dividend. Cardinal Health pays out 31.5% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has raised its dividend for 14 consecutive years and Cardinal Health has raised its dividend for 29 consecutive years. Elevance Health is clearly the better dividend stock, given its higher yield and lower payout ratio.

Elevance Health has a net margin of 2.47% compared to Cardinal Health's net margin of 0.62%. Elevance Health's return on equity of 14.64% beat Cardinal Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health2.47% 14.64% 5.22%
Cardinal Health 0.62%-92.61%4.46%

Elevance Health presently has a consensus target price of $440.90, indicating a potential upside of 10.79%. Cardinal Health has a consensus target price of $251.73, indicating a potential upside of 6.23%. Given Elevance Health's higher probable upside, research analysts clearly believe Elevance Health is more favorable than Cardinal Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65
Cardinal Health
0 Sell rating(s)
3 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.83

Elevance Health has higher earnings, but lower revenue than Cardinal Health. Elevance Health is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$199.13B0.43$5.66B$22.5017.69
Cardinal Health$250.74B0.22$1.56B$6.5436.23

In the previous week, Elevance Health had 2 more articles in the media than Cardinal Health. MarketBeat recorded 10 mentions for Elevance Health and 8 mentions for Cardinal Health. Elevance Health's average media sentiment score of 1.11 beat Cardinal Health's score of 0.61 indicating that Elevance Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
7 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Cardinal Health
1 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 87.2% of Cardinal Health shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by insiders. Comparatively, 0.1% of Cardinal Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

Elevance Health beats Cardinal Health on 14 of the 18 factors compared between the two stocks.

Get Cardinal Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for CAH and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CAH vs. The Competition

MetricCardinal HealthHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$55.56B$10.01B$7.03B$24.20B
Dividend Yield0.87%2.55%2.58%3.69%
P/E Ratio36.2725.52269.9129.10
Price / Sales0.224.85654.6914.15
Price / Cash20.2625.5828.8919.37
Price / Book-21.465.3311.404.91
Net Income$1.56B$309.96M$3.45B$1.06B
7 Day Performance0.80%0.76%3.66%1.35%
1 Month Performance0.61%0.23%-0.49%2.32%
1 Year Performance50.51%23.46%77.51%20.14%

Cardinal Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CAH
Cardinal Health
4.5181 of 5 stars
$236.06
-0.1%
$251.73
+6.6%
+50.3%$55.32B$250.74B36.1157,700
DXCM
DexCom
3.668 of 5 stars
$87.31
+4.6%
$88.46
+1.3%
+7.5%$31.49B$4.66B34.5111,000
MMSI
Merit Medical Systems
3.353 of 5 stars
$85.53
+0.6%
$100.30
+17.3%
+4.0%$5.08B$1.52B35.347,500
AMN
AMN Healthcare Services
2.942 of 5 stars
$33.00
-1.9%
$29.00
-12.1%
+107.6%$1.30B$3.42BN/A2,664
COR
Cencora
4.7982 of 5 stars
$308.21
-1.0%
$367.75
+19.3%
+12.3%$60.57B$321.33B23.6451,000

Related Companies and Tools


This page (NYSE:CAH) was last updated on 8/10/2026 by MarketBeat.com Staff.
From Our Partners